AADACL2 anticorps
-
- Antigène Tous les produits AADACL2
- AADACL2 (Arylacetamide Deacetylase-Like 2 (AADACL2))
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp AADACL2 est non-conjugé
-
Application
- ELISA, Immunohistochemistry (IHC)
- Réactivité croisée
- Humain
- Purification
- Antigen affinity purification
- Immunogène
- Fusion protein of Human AADACL2
- Isotype
- IgG
-
-
- Indications d'application
- ELISA:1:2000-1:5000, IHC:1:25-1:100,
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- -20 °C, pH 7.4 PBS, 0.05 % Sodium azide, 40 % Glycerol
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C,-80 °C
- Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Antigène
- AADACL2 (Arylacetamide Deacetylase-Like 2 (AADACL2))
- Autre désignation
- AADACL2 (AADACL2 Produits)
- Synonymes
- anticorps EG639634, anticorps RGD1563197, anticorps arylacetamide deacetylase like 2, anticorps arylacetamide deacetylase-like 2, anticorps Aadacl2, anticorps AADACL2
- Sujet
-
Background: AADAC is a 45 kDa membrane-associated hydrolase highly expressed in the human liver that has been implicated in the hydrolysis of arylacetamide xenobiotics including flutamide and phenacetin.556-560AADAC is highly homologous to several related lipases, AADACL1, 2, and 4, the latter two of which remain completely unannotated. Overexpression of AADAC in a rat hepatoma cell line produces changes in cellular TG levels, apoplipoprotein B secretion, and fatty acid oxidation, but the mechanism for these effects remains unclear.561 Candidate endogenous substrates, selective inhibitors, or knockout mice have not, to our knowledge, been described for AADAC or the related enzymes AADACL2 and AADACL4.
Aliases: AADACL2Arylacetamide deacetylase-like 2 antibody, EC 3.1.1.- antibody
- UniProt
- Q6P093
-